FTC Seasilver settlement
This article was originally published in The Tan Sheet
Executive Summary
Supplement marketers Americaloe and Seasilver will pay $4.5 mil. in consumer redress and will destroy $5.3 mil. worth of misbranded products as part of a settlement for the dietary supplement Seasilver, FTC announces March 17. The Carlsbad, Calif.-based companies are barred from making false or unsubstantiated claims for any supplement, food or drug and will pay only $3 mil. of the $120 mil. judgement owed due to "their demonstrated inability to pay more," FTC says. The complaint filed in June pointed to claims the product cured cancer and caused rapid, permanent weight loss without dieting (1"The Tan Sheet" June 23, 2003, p. 14)...
You may also be interested in...
Seasilver Seized By U.S. Marshals; FDA/FTC Challenge Companies In Court
U.S. Marshals seized 132,480 bottles of Seasilver liquid dietary supplement from Seasilver USA's San Diego headquarters June 17 at FDA's request
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.